Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2002
12/10/2002US6492396 Substituted thioacetamides
12/10/2002US6492393 Compounds useful as anti-inflammatory agents
12/10/2002US6492387 Isoindolyl and isoquinolinyl aroyl pyrrole compounds
12/10/2002US6492379 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
12/10/2002US6492372 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
12/10/2002US6492367 Sulfamato hydroxamic acid metalloprotease inhibitor
12/10/2002US6492366 Cyano-indole serotonin-reuptake inhibitor compound
12/10/2002US6492129 Fragments comprising the n-terminal region of connective tissue growth factor (ctgf); screening for inhibitors or stimulators of ctgf
12/10/2002CA2208792C Substituted indazole derivatives
12/10/2002CA2092431C 3,9-diazabicyclo (3.3.1) nonan-7-yl derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
12/09/2002WO2002004403A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments
12/09/2002CA2412116A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments
12/08/2002CA2817619A1 Methods of administering anti-tnf.alpha. antibodies
12/08/2002CA2385745A1 Methods of administering anti-tnf.alpha. antibodies
12/05/2002WO2002097120A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
12/05/2002WO2002097060A2 Carbohydrate-associated proteins
12/05/2002WO2002097046A2 B7 related protein-2 molecules and uses thereof
12/05/2002WO2002097033A2 Antibodies that immunospecifically bind to trail receptors
12/05/2002WO2002097032A2 Proteins associated with cell growth, differentiation, and death
12/05/2002WO2002097030A2 Peptides derived from neural thread proteins and their medical use
12/05/2002WO2002096912A1 Novel ligand for nicotinic acetylcholine receptors useful in therapy
12/05/2002WO2002096911A1 Novel heteroaryl-diazabicyclo-alkanes as cns-modulators
12/05/2002WO2002096909A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl) -methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors
12/05/2002WO2002096893A1 Process for preparing a thialzole ppar-ligand and polymorphs thereof
12/05/2002WO2002096891A1 Dihydrodiaryloxazepine derivative and medicinal composition containing the derivative
12/05/2002WO2002096883A1 Tricyclic compounds useful as angiotensin ii agonists
12/05/2002WO2002096876A1 Carbamate and oxamide compounds as inhibitors of cytokine production
12/05/2002WO2002096867A2 Inhibitors of protein kinase for the treatment of disease
12/05/2002WO2002096858A1 Cinnamide derivatives as kcnq potassium channel modulators
12/05/2002WO2002096855A2 Anticholinergic compounds and methods of use
12/05/2002WO2002096449A1 Carbohydrate modifying agent and drinks containing the modifying agent
12/05/2002WO2002096427A1 Pyrimidine derivatives as selective inhibitors of cox-2
12/05/2002WO2002096426A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/05/2002WO2002096421A1 5-substituted-2-arylpyridines as crf1 modulators
12/05/2002WO2002096419A1 Pharmaceutical composition comprising a tricyclic compound for the prevention or treatment of skin diseases
12/05/2002WO2002096404A1 Method of treating gastroesophageal reflux disease and nocturnal acid breakthrough
12/05/2002WO2002096401A1 Solid pharmaceutical formulations comprising modafinil
12/05/2002WO2002096399A1 Lipolysis accelerator, cosmetic skin preparation for body weight reduction and food or beverage composition each containing the same, and method for reducing body weight and medicinal use each based on activity of the same
12/05/2002WO2002096367A2 Targeted multivalent macromolecules
12/05/2002WO2002096363A2 Method for treating fibrotic diseases or other indications
12/05/2002WO2002096362A2 Method for treating fibrotic diseases or other indications vi
12/05/2002WO2002096360A2 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals
12/05/2002WO2002096358A2 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
12/05/2002WO2002096357A2 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method
12/05/2002WO2002096203A1 Stem cell differentiation
12/05/2002WO2002076400A3 Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
12/05/2002WO2002070557A3 Nuclear hormone receptor ligand binding domain
12/05/2002WO2002066450A3 Anthrone derivatives and their use as ink inhibitors
12/05/2002WO2002065978A3 Functional agent for decomposing nicotine and method of preparing the same
12/05/2002WO2002064547A3 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
12/05/2002WO2002062798A3 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose
12/05/2002WO2002028902A3 Nectin polypeptides, polynucleotides, methods of making and use thereof
12/05/2002WO2002013862A3 Method and composition for altering a b cell mediated pathology
12/05/2002WO2002013861A3 Method and composition for altering a t cell mediated pathology
12/05/2002WO2002009637A3 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
12/05/2002WO2001098362A3 Chemically-modified antimicrobial peptides, compositions and methods of production and use
12/05/2002WO2001092491A3 Mammalian protein phosphatases identified by in-silico analysis
12/05/2002WO2001032926A3 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
12/05/2002US20020183514 Useful in the treatment and control of solid tumors
12/05/2002US20020183508 Sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
12/05/2002US20020183503 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of immunological, infectious, inflammatory and cancer disorders
12/05/2002US20020183395 Methods for treating hyperactive gastric motility
12/05/2002US20020183384 Administering sulfonylaminocarbonyl derivative, or a pharmaceutically acceptable salt for therapy of disease or a disorder responsive to inhibition of nuclear factor- kappa B (NF- kappa B)
12/05/2002US20020183375 For therapy of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms
12/05/2002US20020183367 2,1-Oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
12/05/2002US20020183360 Substituted 2-(2,6-dioxopiperidin-3-YL)-phthalimides and -1-oxoisoindolines and method of reducing TNFalpha levels
12/05/2002US20020183349 For therapy and prophylaxis of disorders of the central nervous system; damage to the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes, sleep apnea
12/05/2002US20020183346 Tricyclic androgen receptor modulator compounds and methods
12/05/2002US20020183338 Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as the active ingredient
12/05/2002US20020183334 For therapy of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, treatment of attention deficit hyperactivity disorder
12/05/2002US20020183326 1,2,4-triazolo[4,3-B]pyrido[3,2-D]pyridazine derivatives and pharmaceutical compositions containing them
12/05/2002US20020183323 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy
12/05/2002US20020183319 For therapy of blood vessel proliferative disorders; fibrotic disorders; mesangial cell proliferative disorders; metabolic disorders; allergies; asthma; thrombosis; nervous system diseases; and cancer
12/05/2002US20020183316 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
12/05/2002US20020183313 Cholecystokinin-A and B (CCK-A/B) antagonists and useful in therapy and prophylaxis of disorders of appetite regulatory systems (e.g., anorexia) disorders associated with intestinal smooth muscle hyperactivity (e.g., irritable bowel syndrome)
12/05/2002US20020183289 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its uses
12/05/2002US20020183282 For skin, muscle, ocular or gastric mucosal healing
12/05/2002US20020183271 Administering to the patient a human MDA-7 polypeptide or a nucleic acid expressing the human MDA-7 polypeptide in eukaryotic cells, whereby the MDA-7 polypeptide inhibits angiogenesis in the patient
12/05/2002US20020183263 Nutritional preparation comprising ribose and medical use thereof
12/05/2002US20020183245 For therapy of Porphyromonas (Bacteroides) gingivalis; periodontal disorder
12/05/2002US20020183241 Methods for treating vertigo and motion sickness using descarboethoxyloratadine
12/05/2002US20020182706 Purification of viral envelope proteins; obtain cell, transfect with genetically engineered virus, lyse cell, recover envelope proteins
12/05/2002US20020182671 Polypeptide for use in the treatment, diagnosis, and prevention of cell proliferative, autoimmune/inflammatory, neurological and gatrointestinal disorders
12/05/2002US20020182612 Diagnosing inflammatory defects in humans; obtain nucleotide sequence sample, incubate with probe associated with preferential allele, detect hybridization, hybridization indicates sensitivty to inflammatory defect
12/05/2002US20020182276 Morinda citrifolia (Noni) enhanced animal food product
12/05/2002US20020182274 Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
12/05/2002US20020182269 Cucumis melo extract coated and/or microencapsulated in a fat-soluble agent based on a fatty substance
12/05/2002US20020182267 Compositions to control oral microbial oxidation-reduction (Eh) levels
12/05/2002US20020182265 Lubricious coatings for substrates
12/05/2002US20020182213 Method for the treatment of fibrosis
12/05/2002US20020182188 Making by debulking a suspension of human liver tissue under conditions to remove mature cells, while retaining immature cells having markers for the expression of alpha-fetoprotein, and/or albumin
12/05/2002DE10126434A1 New tricyclic thiochromenone derivatives as metabotropic glutamate receptor-1 (mGluR1) antagonists useful for treating e.g. hemorrhagic stroke and atherosclerosis, especially pain or neurodegenerative diseases
12/05/2002DE10125179A1 Verwendung von LPS zur Behandlung intestinaler Entzündungsprozesse Use of LPS to treat intestinal inflammation
12/05/2002CA2455341A1 Novel ligand for nicotinic acetylcholine receptors useful in therapy
12/05/2002CA2452154A1 Carbohydrate modifying agent and drinks containing the modifying agent
12/05/2002CA2451838A1 Stem cell differentiation
12/05/2002CA2449160A1 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
12/05/2002CA2449009A1 Method of treating gastroesophageal reflux disease and nocturnal acid breakthrough
12/05/2002CA2449006A1 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method
12/05/2002CA2448894A1 Cinnamide derivatives as kcnq potassium channel modulators
1 ... 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 ... 1258